Medical News

RSS

LIJ Medical Center to acquire TrueBeam system for cancer treatment

In a promising development for cancer patients in the New York metropolitan area, the Long Island Jewish (LIJ) Medical Center Department of Radiation Medicine announced today that it will acquire an innovative new system called TrueBeam that offers a radically different approach to treating cancer with image-guided radiotherapy.

22 Apr 2010

Cook Medical enrolls first patient in Formula PTX Balloon Expandable Renal Stent trial

Angiotech Pharmaceuticals, Inc. today announced Cook Medical, a license holder of Angiotech's paclitaxel technology, has enrolled the first patient in its landmark Formula PTX clinical trial. The trial is the first of its kind to evaluate the safety and effectiveness of a paclitaxel-eluting stent to treat renal artery disease, the narrowing of the arteries that supply blood to the kidneys.

22 Apr 2010

People with vitiligo may have less risk of developing malignant melanoma: Research

People with the skin pigmentation disorder vitiligo may have less risk of developing life-threatening malignant melanoma, according to new research. The study also further confirms the suspicion that vitiligo is an autoimmune disease, which occur when the body's immune system reacts against its own tissues or organs.

22 Apr 2010

Legal case asks who to blame for medical device failure

The New York Times: A legal case now pending asks a question increasingly faced by the medical world -- "who should be held accountable when a company sells a flawed product that can injure or kill patients? Is it the company or the people who run it?"

22 Apr 2010

Medtronic acquires Invatec

Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.

22 Apr 2010

DynaVox prices initial public offering at $15.00 per share

DynaVox Inc., a leading provider of software, devices and content to assist people in overcoming their speech, language or learning disabilities, announced today that its initial public offering of 9,375,000 shares of its Class A common stock has been priced at $15.00 per share. The shares are expected to begin trading tomorrow, April 22, 2010, on the NASDAQ Global Select Market under the ticker symbol "DVOX."

22 Apr 2010

Access Pharmaceuticals to present MuGard clinical data at 2010 MASCC conference

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company specializing in products for cancer and supportive care, announced today that it will present data from the ongoing work involving its lead product, MuGard, and host an oral mucositis symposium at the MASCC conference being held in Vancouver, B.C. on June 24-26, 2010. MuGard is Access Pharma's FDA-approved product for the management of oral mucositis, a debilitating side effect of many anticancer treatments.

22 Apr 2010

Mammographic density is one of the strongest predictors of breast cancer risk: Researchers

Women who have a breast density of 75 percent or higher on a mammogram have a risk of breast cancer that is four to five times greater than that of women with little or no density, making mammographic breast density one of the strongest biomarkers of breast cancer risk.

22 Apr 2010

Health record push lacks FDA oversight, risks safety problems

The Huffington Post Investigative Fund: "As federal officials encourage the rapid expansion of electronic medical records to help doctors improve care and cut costs, they lack a reliable and systematic method for tracking the safety of these products, agency data and audits show. Instead, the Food and Drug Administration depends on a spotty warning system that can take a year to flag serious computer malfunctions and other software glitches.

22 Apr 2010

Berwick may face difficult confirmation in Senate

News outlets continue to report on Donald Berwick, who was nominated by President Barack Obama to be administrator of the Centers for Medicare and Medicaid Services.

22 Apr 2010

Positive results from initial clinical trial of ClariVein catheter

Results from the initial clinical trial of the ClariVein® catheter, used in a new minimally invasive treatment for varicose veins, have been announced. The device combines mechanical and chemical modalities to accomplish vein treatment in an in-office setting.

22 Apr 2010

Red wine consumption may protect brain from stroke damage, say Johns Hopkins researchers

Researchers at Johns Hopkins say they have discovered the way in which red wine consumption may protect the brain from damage following a stroke.

22 Apr 2010

OPAL study: Fish oil supplements offer no benefits for cognitive function in older people

The largest ever trial of fish oil supplements has found no evidence that they offer benefits for cognitive function in older people.

22 Apr 2010

Simcere's diosmectite API in generic drug Biqi passes EU-GMP inspection

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that its diosmectite, the Active Pharmaceutical Ingredient (API) in Simcere's branded generic drug Biqi, has passed EU-GMP inspection. This enables Simcere to market diosmectite in the European Union countries.

22 Apr 2010

Online Wiki offers information, comfort and community for families facing autism transition

Among the many challenges families caring for individuals with autism spectrum disorders face, perhaps the most difficult of all arrive "when the school bus stops." When a child with autism ages out of systems and supports designed for those up to ages 18-21, families face the daunting challenge of finding new resources and creating new communities for their children. Unfortunately, finding necessary services and supports can be very difficult.

22 Apr 2010

State's Medicaid funds tapped for federal health overhaul

Kaiser Health News staff writer Christopher Weaver writes: "The new health care law could shift billions of dollars from cash-strapped states to the federal government by changing the way Medicaid prescription drug rebates are treated, according to state and industry officials and an examination of Medicaid spending data" (Weaver, 4/20).

22 Apr 2010

FDA approves Akorn's ANDA supplement for Erythromycin

Akorn, Inc. a niche generic pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of the Company's Abbreviated New Drug Application (ANDA) supplement for Erythromycin Ophthalmic Ointment USP 3.5 g. The company intends to begin shipping the product immediately.

22 Apr 2010

Celldex Therapeutics presents CDX-1127 antibody program at AACR Annual Meeting

Celldex Therapeutics, Inc. today announced that CDX-1127, a preclinical therapeutic antibody program for oncology indications, is the subject of a poster presentation at the 2010 American Association for Cancer Research 101st Annual Meeting in Washington DC.

22 Apr 2010

Abbott acquires Facet Biotech

Abbott has completed its acquisition of Facet Biotech Corporation, strengthening its pharmaceutical pipeline in immunology and oncology.

22 Apr 2010

Alaska is 20th state to join health reform lawsuit; Okla. and La. consider signing on

Alaska Republican Gov. Sean Parnell has said he will make Alaska the 20th state to join a lawsuit challenging the constitutionality of the new health reform law, The Anchorage Daily News/McClatchy report.

21 Apr 2010

Medical News

LIJ Medical Center to acquire TrueBeam system for cancer treatment

Cook Medical enrolls first patient in Formula PTX Balloon Expandable Renal Stent trial

People with vitiligo may have less risk of developing malignant melanoma: Research

Legal case asks who to blame for medical device failure

Medtronic acquires Invatec

DynaVox prices initial public offering at $15.00 per share

Access Pharmaceuticals to present MuGard clinical data at 2010 MASCC conference

Mammographic density is one of the strongest predictors of breast cancer risk: Researchers

Health record push lacks FDA oversight, risks safety problems

Berwick may face difficult confirmation in Senate

Positive results from initial clinical trial of ClariVein catheter

Red wine consumption may protect brain from stroke damage, say Johns Hopkins researchers

OPAL study: Fish oil supplements offer no benefits for cognitive function in older people

Simcere's diosmectite API in generic drug Biqi passes EU-GMP inspection

Online Wiki offers information, comfort and community for families facing autism transition

State's Medicaid funds tapped for federal health overhaul

FDA approves Akorn's ANDA supplement for Erythromycin

Celldex Therapeutics presents CDX-1127 antibody program at AACR Annual Meeting

Abbott acquires Facet Biotech

Alaska is 20th state to join health reform lawsuit; Okla. and La. consider signing on

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News